MedPath

Ibuprofen

Generic Name
Ibuprofen
Brand Names
Addaprin, Advil, Advil Cold and Sinus, Advil Congestion Relief, Advil PM, Advil Sinus Congestion and Pain, Alivio, Caldolor, Cedaprin, Children's Ibuprofen, Diphen, Duexis, Ibu, Ibutab, Junior Strength Motrin, Motrin, Motrin PM, Neoprofen, Nuprin, Pedea, Proprinal, Reprexain, Sudafed PE Head Congestion Plus Pain, Vicoprofen, Wal-profen Congestion Relief and Pain, Ibuprofen Gen.Orph
Drug Type
Small Molecule
Chemical Formula
C13H18O2
CAS Number
15687-27-1
Unique Ingredient Identifier
WK2XYI10QM
Background

Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics. The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin. Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID.

On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo by the activity of the alpha-methylacyl-CoA racemase. In particular, it is generally proposed that the S-enantiomer is capable of eliciting stronger pharmacological activity than the R-enantiomer.

Indication

Ibuprofen is the most commonly used and prescribed NSAID. It is a very common over-the-counter medication widely used as an analgesic, anti-inflammatory and antipyretic.

The use of ibuprofen and its enantiomer Dexibuprofen in a racemic mix is common for the management of mild to moderate pain related to dysmenorrhea, headache, migraine, postoperative dental pain, spondylitis, osteoarthritis, rheumatoid arthritis, and soft tissue disorder.

Due to its activity against prostaglandin and thromboxane synthesis, ibuprofen has been attributed to alteration of platelet function and prolongation of gestation and labour.

As ibuprofen is a widely used medication, the main therapeutic indications are:

Associated Conditions
Acute Pain, Ankylosing Spondylitis (AS), Common Cold, Cystic Fibrosis (CF), Fever, Gastric Ulcer, Gout, Headache, Insomnia, Juvenile Idiopathic Arthritis (JIA), Menstrual Distress (Dysmenorrhea), Migraine, Mild pain, Nasal Congestion, Osteoarthritis (OA), Pain, Pain, Inflammatory, Patent Ductus Arteriosus (PDA), Pericarditis, Primary Dysmenorrhoea, Rheumatoid Arthritis, Severe Pain, Sinus pressure, Mild to moderate pain, Minor aches and pains, Moderate Pain

Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies

Phase 4
Withdrawn
Conditions
Ductus Arteriosus, Patent
Very Low Birth Weight Infants
Interventions
First Posted Date
2007-05-08
Last Posted Date
2015-09-02
Lead Sponsor
KK Women's and Children's Hospital
Registration Number
NCT00470743
Locations
🇸🇬

KK Women's and Children's Hospital / National University Hospital, Singapore, Singapore

Myogenic and Osteogenic Responses to eXercise and Ibuprofen

Not Applicable
Completed
Conditions
Aging
Physical Fitness
Interventions
Drug: Placebo
Behavioral: musculoskeletal-loading exercise
First Posted Date
2007-04-19
Last Posted Date
2015-11-01
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
159
Registration Number
NCT00462722
Locations
🇺🇸

University of Colorado Denver, Aurora, Colorado, United States

Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment

Phase 3
Completed
Conditions
Ulcer
Interventions
First Posted Date
2007-03-22
Last Posted Date
2024-12-16
Lead Sponsor
Amgen
Target Recruit Count
906
Registration Number
NCT00450216

Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers

Phase 3
Completed
Conditions
Peptic Ulcer
Interventions
First Posted Date
2007-03-22
Last Posted Date
2024-12-16
Lead Sponsor
Amgen
Target Recruit Count
627
Registration Number
NCT00450658

Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA

Phase 3
Completed
Conditions
Patent Ductus Arteriosus
First Posted Date
2007-02-27
Last Posted Date
2007-02-27
Lead Sponsor
Farmacon
Registration Number
NCT00440804

Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin

Phase 1
Completed
Conditions
Osteoarthritis
Interventions
First Posted Date
2006-12-13
Last Posted Date
2017-10-04
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
32
Registration Number
NCT00411190
Locations
🇧🇪

GSK Investigational Site, Liège, Belgium

Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops

Not Applicable
Completed
Conditions
Glaucoma
Ocular Hypertension
Interventions
First Posted Date
2006-11-22
Last Posted Date
2018-04-04
Lead Sponsor
Philadelphia Eye Associates
Target Recruit Count
51
Registration Number
NCT00402493
Locations
🇺🇸

Philadelphia Eye Associates, Philadelphia, Pennsylvania, United States

Premedication to Reduce Discomfort With Screening Mammography

Phase 4
Completed
Conditions
Breast Pain
First Posted Date
2006-09-28
Last Posted Date
2006-09-28
Lead Sponsor
Mountain States Tumor and Medical Research Institute
Registration Number
NCT00382083
Locations
🇺🇸

St. Luke's Mountain States Tumor Institute Breast Cancer Detection Center, Boise, Idaho, United States

Effectiveness Of Single Doses Of Ibuprofen In Patients With Osteoarthritis Of The Knee

Phase 1
Completed
Conditions
Osteoarthritis
First Posted Date
2006-09-07
Last Posted Date
2008-10-16
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
36
Registration Number
NCT00372801
Locations
🇦🇺

GSK Investigational Site, Randwick, Sydney, New South Wales, Australia

Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen

Phase 4
Completed
Conditions
Arthritis, Rheumatoid
Interventions
First Posted Date
2006-06-29
Last Posted Date
2021-03-03
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Target Recruit Count
24081
Registration Number
NCT00346216
Locations
🇺🇸

Orange County Research Center, Tustin, California, United States

🇺🇸

AnMed Health, Anderson, South Carolina, United States

🇺🇸

Wagdy W. Kades, MD, Inc., Los Angeles, California, United States

and more 1037 locations
© Copyright 2025. All Rights Reserved by MedPath